NFKB1 and agammaglobulinemia: We distinguish PIDs such as XLP and STAT3 mutations, which do not typically present with antibody deficiency (41–43) from disorders such as NFKB1 mutations which, most often present with hypogammaglobulinemia, that are more appropriately termed CVID-like disorders (19).